AI Article Synopsis

  • Exercise capacity is vital for managing COPD, impacting both quality of life and mortality; traditional tests like CPET and 6MWT have limitations that hinder their everyday use.
  • The study examined the 4-meter gait speed (4mGS) in 23 COPD patients, finding significant correlations between 4mGS and other measures such as peak VO2 and 6MWT distance, as well as general health assessments (CAT and BODE).
  • 4mGS shows promise as an easy and reproducible method for evaluating exercise capacity in COPD patients, though further research with larger groups is necessary to validate these findings.

Article Abstract

Introduction: Determination of exercise capacity is crucial for chronic obstructive pulmonary disease (COPD) management since it is an indicator of life quality and mortality. Various previously defined tests, including the cardiopulmonary exercise test (CPET), the 6-minute walking test (6MWT), and the incremental shuttle walk test, are used to determine COPD patients' exercise capacity. However, they all have some disadvantages, such as time, personnel, and equipment requirements, limiting their daily practice use. Here, it was aimed to investigate the role of 4-meter gait speed (4mGS) in evaluating exercise capacity in COPD.

Materials And Methods: We included 40-to-70-year-old COPD patients with no contraindications for exercise testing. We performed the tests at standard intervals without affecting each other's results. We also performed spirometry. We used the modified Medical Research Council Scale, COPD Assessment Test, and BODE index to determine the current status of individuals.

Result: Twenty-three (female/male= 2/21) subjects aged 58.1 ± 7.3 were included in the study. A statistically significant correlation was observed between 4mGS and peak VO2 values. There was also a statistically significant relationship between 4mGS and 6MWT distance. 4mGS correlated with CAT and BODE scores to represent the general medical status of patients.

Conclusions: Considering its easy applicability and reproducibility, 4mGS seems to be a strong candidate for daily clinical use in monitoring the exercise capacity of COPD patients. Further studies in larger patient groups are needed to support these results.

Download full-text PDF

Source
http://dx.doi.org/10.5578/tt.20229907DOI Listing

Publication Analysis

Top Keywords

exercise capacity
20
capacity copd
8
4-meter gait
8
gait speed
8
copd patients
8
exercise
7
copd
6
capacity
5
4mgs
5
basic tool
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!